SCHEMBL807449

SCHEMBL807449

CC(C)C1CNC[C@H]1c1cccc(-c2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
KIF11 P52732 1/20 0.35
KDM1A O60341 2/20 0.35
MAOA P21397 2/20 0.35
HTR2C P28335 6/20 0.35
HTR2A P28223 4/20 0.35
HTR2B P41595 4/20 0.35
HRH3 Q9Y5N1 2/20 0.35
HSD17B2 P37059 1/20 0.34
ROCK2 O75116 1/20 0.34
GPR88 Q9GZN0 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
HTR1A P08908 1/20 0.33
HTR7 P34969 1/20 0.33
CYP2D6 P10635 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15081942 1.00 SLC6A2 (0.37) SLC6A2SLC6A4SLC6A3KIF11KDM1A
SCHEMBL15082019 1.00 SLC6A2 (0.37) SLC6A2SLC6A4SLC6A3KIF11KDM1A
SCHEMBL807454 0.85 MAOA (0.43) SLC6A2SLC6A3KIF11KDM1AMAOA
SCHEMBL17084154 0.85 MAOA (0.43) SLC6A2SLC6A3KIF11KDM1AMAOA
SCHEMBL17084189 0.85 MAOA (0.43) SLC6A2SLC6A3KIF11KDM1AMAOA
SCHEMBL15081932 0.85 MAOA (0.43) SLC6A2SLC6A3KIF11KDM1AMAOA
SCHEMBL15084369 0.80 KDM1A (0.37) SLC6A2SLC6A4SLC6A3KDM1AMAOA
SCHEMBL15082020 0.75 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3HRH3HSD17B2
SCHEMBL15081944 0.75 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3HRH3HSD17B2
SCHEMBL15081930 0.70 HTR2C (0.37) SLC6A2SLC6A4SLC6A3HTR2CHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012036997-A1 FUSED PYRAZOLE DERIVATIVES AS NOVEL ERK INHIBITORS SCHERING CORPORATION (US) 2012-03-22 WO disclosed